rofecoxib has been researched along with Retinal Neovascularization in 2 studies
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the anti-angiogenesis mechanism of Rofecoxib and determine whether Rofecoxib can be a therapeutic agent for the prevention of retinal neovascularization using a model of retinopathy of prematurity (ROP)." | 7.81 | Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression. ( Chen, L; Liu, NN; Sun, YZ; Zhao, N, 2015) |
| "To explore the anti-angiogenesis mechanism of Rofecoxib and determine whether Rofecoxib can be a therapeutic agent for the prevention of retinal neovascularization using a model of retinopathy of prematurity (ROP)." | 3.81 | Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression. ( Chen, L; Liu, NN; Sun, YZ; Zhao, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, NN | 1 |
| Sun, YZ | 1 |
| Zhao, N | 1 |
| Chen, L | 1 |
| Wilkinson-Berka, JL | 1 |
| Alousis, NS | 1 |
| Kelly, DJ | 1 |
| Gilbert, RE | 1 |
2 other studies available for rofecoxib and Retinal Neovascularization
| Article | Year |
|---|---|
Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
Topics: Animals; Animals, Newborn; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease | 2015 |
COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, A | 2003 |